Picture of Vertex Pharmaceuticals logo

VRTX Vertex Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

U.S. RESEARCH ROUNDUP-Incyte, ServiceNow, Spire Global

Dec 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Incyte, ServiceNow and Spire Global, on Wednesday.

HIGHLIGHTS

* Incyte INCY.O: Truist Securities raises target price to $103 from $93
* ServiceNow NOW.N: TD Cowen adjusts PT to $250 from $1,250 to reflect 5-for-1 stock split
* Spire Global Inc SPIR.N: Alliance Global Partners cuts to neutral from buy
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* DTE Energy Co DTE.N: BMO cuts target price to $148 from $151
* Gemini Space Station Inc GEMI.O: Mizuho cuts target price to $26 from $30
* Huron Consulting Group Inc HURN.O: Benchmark raises target price to $215 from $180
* Incyte INCY.O: Truist Securities raises target price to $103 from $93
* ServiceNow NOW.N: TD Cowen adjusts PT to $250 from $1,250 to reflect 5-for-1 stock split
* ServiceNow NOW.N: TD Cowen cuts target price to $230 from $250
* Spire Global Inc SPIR.N: Alliance Global Partners cuts target price to $9 from $17
* Spire Global Inc SPIR.N: Alliance Global Partners cuts to neutral from buy
* US Bancorp USB.N: Argus Research raises target price to $62 from $52
* Vertex Pharmaceuticals Inc VRTX.O: Leerink Partners raises PT to $525 from $456
* Vse Corp VSEC.O: Jefferies raises target price to $215 from $210
* Whitefiber Inc WYFI.O: B. Riley cuts target price to $40 from $44
(Compiled by Bengaluru Newsroom) ((Diaries@thomsonreuters.com))

Recent news on Vertex Pharmaceuticals

See all news